The Bill & Melinda Gates Foundation pledged $750 million to establish the Global Fund for Children’s Vaccines
On Nov. 23, 1999, the Bill & Melinda Gates Foundation pledged a gift of $750 million over five…
ACIP voted to withdraw their recommendation for rotavirus vaccine
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
The CDC identified and responded to West Nile Virus in New York City
In August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
ACIP recommended exclusive use of inactivated poliovirus vaccine (IPV) for infants and children
On Jun. 17, 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
The Dale and Betty Bumpers Vaccine Research Center was established
On Jun. 9, 1999, the Dale and Betty Bumpers Vaccine Research Center (VRC) was established at the National…
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
Biotechnology | CDC | FDA | Infectious Disease | Vaccine
ACIP recommended DTaP vaccines for all five doses in the vaccination schedule
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
A meningococcal group C conjugate vaccine was introduced into the routine schedule in the UK
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
The CDC launched the National Pharmaceutical Stockpile for emergency health security
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
The CDC’s Laboratory Response Network was established
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
Rotavirus vaccine, live, oral, tetravalent was licensed
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…
The Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health (PATH)
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American Vaccine) was licensed
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…
The Stop TB Partnership was established
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
Research caused concern that hepatitis B vaccination might be linked with multiple sclerosis
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
Biotechnology | FDA | Vaccine
Rabies vaccine (RabAvert by Chiron Behring) was licensed
On Oct. 20, 1997, the Food and Drug Administration (FDA) licensed Purified Chick Embryo Cell (PCEC, RabAvert®) vaccine…
ACIP recommended booster doses of pneumococcal polysaccharide vaccine
On April 4, 1997, the Immunization Practices Advisory Committee (ACIP) recommended that the vaccine be used more extensively…
Biotechnology | Chemical | Disease | Genomics | Life Science History | Medicine | Nanotechnology | NIH | Non-Profit Research | Therapeutics | Vaccine
American Association for the Advancement of Science held in Seattle for the first time since 1940
On Feb. 13, 1997, the American Association for the Advancement of Science (AAAS) Annual Meeting and Science Innovation…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
ACIP recommended adoption of a sequential series of two doses of IPV followed by two doses of OPV for all infants and children
In 1997, the Immunization Practices Advisory Committee (ACIP) recommended adoption of a sequential series of two doses of…
Biotechnology | Diagnostics | Influenza | Vaccine | WHO
FluNet, a web-based flu surveillance tool, was launched by the WHO
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
First human infection with an avian influenza A H5N1 virus was identified in Hong Kong
In 1997, the H5N1 bird flu incident in Hong Kong was the first known instance of a purely…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 30, 1996, the Food and Drug Administration (FDA) announced it had licensed three DTaP vaccines for…
A combined Haemophilus influenzae type b conjugate and hepatitis B vaccine was licensed
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
Combination DTaP and Hib vaccine was licensed for the fourth dose in the DTaP and Hib series
On Sept. 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined…
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed was licensed
On Jul. 31, 1996, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Tripedia by Aventis Pasteur)…
The Interational AIDS Vaccine Initiative (IAVI) was launched
On Jun. 18, 1996, the International AIDS Vaccine Initiative (IAVI) was launched, calling for the speedy development of…
A second inactivated hepatitis A vaccine (Vaqta by Merck) was licensed
On Mar. 29, 1996, the second inactivated hepatitis A vaccine (Vaqta by Merck) was licensed.
Avian influenza H5N1 virus was first isolated from a farmed goose in China
In 1996, A/goose/Guangdong/1/1996 (H5N1), the precursor of the highly pathogenic H5N1 avian influenza viruses (HPAIVs) was identified in…